Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Sunvozertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Sunvozertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Surufatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Surufatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Talazoparib	PARP Inhibitor	Solid Tumour
Molecule Talazoparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Taletrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Taletrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Telatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Telatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tepotinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Tepotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Tivantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Tivantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tivozanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Tivozanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tovorafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Tovorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Trametinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Trametinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Triciribine	AKT Inhibitor	Solid Tumour
Molecule Triciribine Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Trilaciclib	CDK Inhibitor	Solid Tumour
Molecule Trilaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

Sunvozertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Surufatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Talazoparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Taletrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Telatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tepotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Tivantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tivozanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tovorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Trametinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Triciribine Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Trilaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

‹ 1 … 9 10 11 12 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Sunvozertinib

Surufatinib

Talazoparib

Taletrectinib

Telatinib

Tepotinib

Tivantinib

Tivozanib

Tovorafenib

Trametinib

Triciribine

Trilaciclib

Sunvozertinib

Surufatinib

Talazoparib

Taletrectinib

Telatinib

Tepotinib

Tivantinib

Tivozanib

Tovorafenib

Trametinib

Triciribine

Trilaciclib